Literature DB >> 17915644

Synthesis of 3-substituted-5-(4-carb oxycyclohexylmethyl) - tetrahydro-2H-1,3,5-thiadiazine-2-thione derivatives as antifibrinolytic and antimicrobial agents.

Azime Berna Ozçelik1, Seyhan Ersan, Ali Uğur Ural, Semiha Ozkan, Mevlüt Ertan.   

Abstract

A series of 3-substituted-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5thiadiazine-2-thione derivatives was prepared and examined for antifibrinolytic and antimicrobial activities. Their structures were elucidated by spectral methods. Antifibrinolytic activities of these compounds, were investigated in vitro and compared to tranexamic acid (CAS 1197-18-8). Among the synthesized compounds, 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (Ia) was the most prominent one (104%) when compared to tranexamic acid. Besides, 3-ethyl-5-(4-carboxycyclohexyl-methyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (Ib), 3-iso-propyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (Id) and 3-isobutyl-5-(4-carboxycyclohexyl-methyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (Ig) showed antifibrinolytic activity similar to tranexamic acid. Antibacterial activities of these compounds against Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis), Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) and yeast-like fungi (Candida albicans, Candida tropicalis) were investigated by the micro-dilution method and compared with the activity of tranexamic acid, ofloxacin and fluconazole. By this way their minimal inhibitory concentration (MIC), minimal bactericidal concentration (MBC) and minimal fungicidal concentration (MFC) values were determined. Compound Ia exhibited almost equally potent activity against B. subtilis (MIC and MBC: 6.25 microg/mL). Compounds Ib-Id, If-Ig and In exhibited similar bactericidal activity against B. subtilis (MBC: 12.5 microg/mL). Compounds Ik and Im showed bacteriostatic activity against S. aureus. None of the compounds exhibited activity against Gram-negative bacteria. On the other hand, all compounds had potent antifungal activities against the yeast utilized. Among the synthesized compounds, 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (Ia) seems to be the most effective compound with antifibrinolytic and antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17915644     DOI: 10.1055/s-0031-1296648

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  5 in total

1.  A computational approach to the synthesis of 1,3,5-thiadiazinane-2-thiones in aqueous medium: theoretical evidence for water-promoted heterocyclization.

Authors:  Julieta Coro; Ramon Alvarez-Puebla; Ana L Montero; Margarita Suárez; Nazario Martin; Rolando Perez-Pineiro
Journal:  J Mol Model       Date:  2008-05-17       Impact factor: 1.810

2.  Thiadiazine derivatives as antiprotozoal new drugs.

Authors:  Julieta Coro Bermello; Rolando Pérez Piñeiro; Lianet Monzote Fidalgo; Hortensia Rodríguez Cabrera; Margarita Suárez Navarro
Journal:  Open Med Chem J       Date:  2011-03-09

3.  Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes.

Authors:  Ece Avuloğlu-Yılmaz; Deniz Yüzbaşıoğlu; Azime Berna Özçelik; Seyhan Ersan; Fatma Ünal
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Thiadiazines, N,N-heterocycles of biological relevance.

Authors:  Hortensia Rodríguez; Margarita Suárez; Fernando Albericio
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

5.  Selected Thiadiazine-Thione Derivatives Attenuate Neuroinflammation in Chronic Constriction Injury Induced Neuropathy.

Authors:  Sonia Qureshi; Gowhar Ali; Muhammad Idrees; Tahir Muhammad; Il-Keun Kong; Muzaffar Abbas; Muhammad Ishaq Ali Shah; Sajjad Ahmad; Robert D E Sewell; Sami Ullah
Journal:  Front Mol Neurosci       Date:  2021-12-16       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.